Krystal Biotech's VYJUVEK, a first-mover gene therapy for DEB, has received a positive CHMP recommendation. Read why KRYS ...
STOCKHOLM, Feb. 28, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced today that the Committee for Medicinal Products for Human Use (CHMP ...
The Scientific Advisory Group (SAG) has been called in to assist the EMA’s CHMP human medicines committee ... for a SAG meeting is “a commonly used procedure for new treatments and new ...
“Today’s positive opinion by the CHMP marks an important step forward in offering a potentially new and differentiated treatment option for people living with this chronic and debilitating ...
Zacks.com on MSN5mon
Novartis Gets CHMP Recommendation for Kisqali in Broader PopulationThe CHMP adopted a positive opinion for the marketing authorization for Kisqali for the adjuvant treatment of adults with ...
The North Chicago, Ill., biopharmaceutical company said the European Commission, which generally follows the CHMP's advice, is expected to make a final decision in the first half of the year.
Jaypirca is one of Lilly’s several new drugs that have contributed to top-line growth in 2024. It recorded $337.0 million in sales in 2024. The drug is also being studied in earlier lines of ...
CHMP of the European Medicines Agency based its positive opinion on results from the AEGEAN trial. Imfinzi is approved in the US and several other countries in this setting. The company noted that ...
Viehbacher, "Biogen") announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has reaffirmed its positive opinion by consensus for the anti ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback